GHK-Cu, known as copper peptide, appears in research on collagen, skin repair, and cosmetics. There is a biological rationale for studying it: experiments with fibroblasts and animal models have demonstrated activity on connective tissue components. What these results do not yet allow is promising broad rejuvenation, an imperceptible scar, or the same benefits for any product containing the ingredient. [1, 2]

The essential distinction is between biological activity and proven clinical benefit. To evaluate GHK-Cu, the formulation, route of administration, and the condition being treated matter. A diabetic ulcer study, for example, answers a different question than a study on wrinkles or post-laser recovery. [3, 4]

What is GHK-Cu?

GHK identifies a sequence of three amino acids: glycine, histidine, and lysine. Therefore, it is a tripeptide. When bound to copper, it forms the GHK-Cu complex. Early literature described GHK in human plasma and investigated its interaction with this metal. [1]

This biological origin does not automatically turn a commercial product into a safe or effective treatment. To make that transition, it would be necessary to know, among other aspects, the identity and purity of the ingredient, its stability, how much reaches the tissue, and what outcomes appear in the people who use it.

Nor should GHK-Cu be confused with any substance described as a peptide. Epitalon investigated in telomere biology and the hexapeptides used in cosmetics are other topics in this series, with different molecules, hypotheses, and evidence.

Why is there interest in collagen and tissue repair?

In a study published in 1988, the GHK-Cu complex stimulated collagen synthesis in fibroblast cultures. These are cells involved in producing the extracellular matrix, the structure that supports tissues. In 1993, another study found greater accumulation of connective tissue components in experimental wounds in rats. [1, 2]

These findings justify research, but they do not directly answer questions such as: does the cream reduce noticeable wrinkles? Does the result last? Is there an advantage over the same moisturizer without the peptide? Does the additional cost translate into meaningful benefit?

Producing more collagen in an experimental condition is not synonymous with producing clinically better skin. Interpretation depends on where, how, and for how long this response occurs. This is especially important when marketing extrapolates results from cells to patients without demonstrating the intermediate clinical step.

What do human studies actually show?

Wounds: a specific indication

A 1994 multicenter trial evaluated the topical treatment of ulcers in people with diabetes and found favorable outcomes in healing measures. Treatment occurred alongside standardized care, including debridement and offloading pressure from the wound. Therefore, the study did not evaluate an over-the-counter cosmetic, nor did it demonstrate that the peptide replaces treating the underlying cause of the lesion. [3]

The difference between this situation and a surgical incision is detailed in the article on GHK-Cu, wound healing, and scars.

After laser: objective results not confirmed

In the study by Miller and colleagues, published in 2006, 13 participants completed the comparison of post–CO2 laser care with or without GHK-Cu. There was no statistically significant difference between the groups in objective measurements of redness, wrinkles, or skin quality. Subjective satisfaction favored the group with the ingredient. [4]

The small number of participants limits precision. Even so, the negative result in objective measurements must be presented, rather than omitted to construct an exclusively favorable narrative. Satisfaction and instrumental improvement are distinct pieces of information; both can be relevant, but they are not interchangeable.

The formulation matters as much as the ingredient's name

The skin constitutes a barrier. For a molecule applied to the surface to produce a given effect, it must remain stable and reach the target site in sufficient quantity. In an experimental study published in 2015, microneedles increased the passage of GHK-Cu through human skin studied outside the body. This was an investigation of delivery of the substance, not a demonstration of rejuvenation in patients. [5]

For this reason, it is not accurate to treat a serum, a cream, an experimental dressing, and a microneedle-associated formulation as if they were the same treatment. The study of one of these presentations does not automatically validate the others.

The same caution applies to the concentration highlighted on the label. Before interpreting a percentage, it is necessary to know what it describes: the active ingredient, a complex, or a commercial solution. The percentage alone does not provide information on stability, absorption, quality, or clinical superiority.

What about eyebrows and hair?

A preliminary 2026 study evaluated 18 adults with thinning eyebrows. Over 12 weeks, one eyebrow received a serum described by the authors as containing 2% GHK-Cu, while the other received the vehicle. The abstract reports improvement in hair count and diameter. The source consulted was the original publication page, not a review that merely mentions the work. [6]

It is an initial signal, limited to that specific formulation and population. It does not establish a treatment for all causes of hair loss, nor does it determine long-term results. Eyebrows and scalp should also not be treated as equivalent outcomes.

Are topical and injectable GHK-Cu the same discussion?

No. The topical evidence presented here does not establish safety, dosage, or benefit for injectable applications. Neither the ulcer study, nor the laser study, nor the eyebrow study was designed to demonstrate systemic rejuvenation via injection. [3, 4, 6]

In Brazil, Anvisa clarifies that injectable products cannot be regulated as cosmetics. This category rule should not be confused with a statement about all products containing a given molecule; it means that cosmetic registration or presentation does not authorize its use via injection. [7]

The term “natural peptide” also does not replace the demonstration of safety. The relevant question is not merely whether the substance exists in the body, but whether the product, via the proposed route and conditions, has been adequately studied.

How to interpret a result without overestimating the product

A before-and-after photograph may spark interest, but on its own, it does not separate the effect of GHK-Cu from other factors. Changes in lighting, concomitant products, and natural variation can hinder comparison. That is why controlled studies are important: they seek to establish whether there was an additional benefit compared to an appropriate comparator.

In the case of a multi-ingredient serum, any observed improvement belongs, first and foremost, to the complete formulation. To attribute the result specifically to the peptide, the study design must allow for this separation. The fact that an ingredient has a plausible mechanism does not resolve this methodological limitation.

It is also important to know whether the difference is noticeable and relevant to the person using the product. A microscopic or statistical change may be scientifically interesting without representing the transformation suggested by advertising.

What is the place of GHK-Cu in a skincare routine?

The most prudent interpretation is to consider it an ingredient of interest whose usefulness must be evaluated in the specific formulation and indication. It should not displace skincare practices that have their own established evidence. Sun protection, for example, was evaluated in a randomized trial with 903 adults over 4.5 years, showing less progression of photoaging in the daily-use group. This study did not compare sunscreen to GHK-Cu; it demonstrates the independent value of prevention. [8]

For someone concerned with wrinkles, the discussion should begin with the objective: improving texture, superficial fine lines, or expression-related marks? The choice becomes clearer when the concern is defined before the ingredient. The article on hexapeptides and wrinkle treatments explores this comparison without equating cosmetics to procedures.

On newly operated skin or skin that has undergone procedures, guidance from the responsible medical team must precede the introduction of any new products. Recommendations for wound and scar care distinguish between an open lesion and already closed skin. [9, 10]

What would be needed for stronger recommendations?

Future studies would be more useful if they described the exact formulation, compared the product to its vehicle, followed participants for an adequate period of time, and systematically recorded adverse effects. They would also need to prespecify the primary outcome: wrinkles, wound closure time, final appearance of the scar, or hair growth.

This separation prevents a favorable result on one measure from being presented as confirmation of all advertised benefits. It is a methodological requirement, not a rejection of the development of new technologies.

Frequently asked questions

1. Is GHK-Cu collagen?

No. It is a complex of a tripeptide with copper. The interest in collagen stems from responses observed in experimental studies, not from the product itself being collagen. [1]

2. Is it proven to rejuvenate the skin?

The cited literature supports experimental activity and some clinical signs, but not a broad promise of rejuvenation. The small post-laser study did not confirm an additional objective benefit. [4]

3. Does it work for any scar?

There is no such demonstration in the presented sources. The favorable study in diabetic ulcers does not establish a treatment for surgical scars, keloids, or acne scars. [3]

4. Can I use a cosmetic product over sutures?

Do not apply a product to the incision on your own. Follow the instructions of the team that performed the surgery, including when the skin can receive topical products. [9]

5. Does a higher concentration mean greater results?

One cannot conclude this without comparative studies and without knowing what the percentage represents. The number on the label alone does not answer these questions.

6. Does research justify at-home microneedling?

No. The skin permeation study investigated an experimental delivery system; it did not validate combining a standard cosmetic with at-home devices. [5]

7. Is there evidence for eyebrows?

There is a small 2026 study involving 18 participants with a 12-week follow-up. It is preliminary and does not demonstrate a universal treatment for hair loss. [6]

8. Does topical use validate injectable use?

No. These are different routes of administration. In Brazil, regulatory approval as a cosmetic does not authorize injecting the product. [7]

9. Does it replace sunscreen?

No. It is not presented here as a photoprotector. Preventing photoaging through sunscreen use is backed by its own dedicated clinical evidence. [8]

10. What is the most balanced conclusion?

GHK-Cu warrants research, but each product and indication requires specific demonstration. The available findings do not justify turning a biological possibility into a promise of individual results.

Educational content. This article does not prescribe products, concentrations, or routes of administration and does not replace an individual medical evaluation.

References

Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. doi:10.1016/0014-5793(88)80509-x | PMID:3169264
Maquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-2376. doi:10.1172/JCI116842 | PMID:8227353
Mulder GD, Patt LM, Sanders L, Rosenstock J, Altman MI, Hanley ME, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994;2(4):259-269. doi:10.1046/j.1524-475X.1994.20406.x | PMID:17147644
Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259. doi:10.1001/archfaci.8.4.252 | PMID:16847171
Li H, Low YSJ, Chong HP, Zin MT, Lee CY, Li B, et al. Microneedle-Mediated Delivery of Copper Peptide Through Skin. Pharm Res. 2015;32(8):2678-2689. doi:10.1007/s11095-015-1652-z | PMID:25690343
Bo SL, Nararatwanchai T, Supornpun N, Poomarapan K, Thaploka S. The efficacy of 2% copper peptide (GHK-Cu) serum for eyebrow hypotrichosis: a randomized, double-blind, vehicle-controlled, split-face comparative study. Procedia of Multidisciplinary Research. 2026;4(5). Published on May 22, 2026. Original source
Agência Nacional de Vigilância Sanitária. Cosméticos para tratamentos estéticos [Internet]. [cited Nov 1, 2026]. Original source
Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790. doi:10.7326/0003-4819-158-11-201306040-00002 | PMID:23732711
American Academy of Dermatology Association. Minimize a scar: Proper wound care tips from dermatologists [Internet]. [cited Nov 1, 2026]. Original source
American Academy of Dermatology Association. Scars: Diagnosis and treatment [Internet]. [cited Nov 1, 2026]. Original source

Note on Sources

Narrative, non-systematic review. The literature search and cross-referencing were conducted on November 1, 2026. References 1, 2, 3, 4, 5, 6, and 8 were used based on the available abstract and metadata; this limits the detailed assessment of methods and risk of bias. Clinical interpretations were kept within these limits. Links to other sites in this series are complementary reading, not substitutes for scientific sources.

GHK-Cu: What Science Shows About the Copper Peptide for the Skin